| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/JVH.12519 |
| P698 | PubMed publication ID | 27028545 |
| P2093 | author name string | P J Easterbrook | |
| S K Basnayake | |||
| P2860 | cites work | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q21534928 |
| Epidemiology of hepatitis C virus infection | Q22305500 | ||
| Genetic history of hepatitis C virus in East Asia | Q24655361 | ||
| Hepatitis B virus: inactive carriers | Q24810833 | ||
| Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection | Q24815355 | ||
| The natural history of hepatitis C virus (HCV) infection | Q27473116 | ||
| Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors | Q27488116 | ||
| Factors Associated with Prevalent Hepatitis C Infection Among HIV-Infected Women with No Reported History of Injection Drug Use: The Women's Interagency HIV Study (WIHS) | Q27490928 | ||
| Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
| EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 | ||
| Global epidemiology of hepatitis C virus infection | Q27860799 | ||
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
| Hepatitis C virus infection | Q27861002 | ||
| Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes | Q27861119 | ||
| Hepatitis C in the HIV-Infected Person | Q28206126 | ||
| Comparison of efficacy and safety of tenofovir and entecavir in chronic hepatitis B virus infection: a systematic review and meta-analysis | Q28539472 | ||
| Hepatitis B in China | Q29031945 | ||
| EASL clinical practice guidelines: Management of chronic hepatitis B virus infection | Q29615868 | ||
| Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence | Q29616009 | ||
| The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide | Q29616215 | ||
| Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment | Q37132382 | ||
| Epidemiology of HCV infection | Q37232821 | ||
| Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV | Q37252421 | ||
| Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells | Q37328900 | ||
| EASL Clinical Practice Guidelines: management of chronic hepatitis B. | Q37340737 | ||
| Hepatitis C infection and chronic renal diseases | Q37364331 | ||
| National Institutes of Health consensus development conference statement: management of hepatitis B. | Q37462573 | ||
| Benefits and risks of interferon therapy for hepatitis B. | Q37462578 | ||
| Chronic hepatitis B: update 2009 | Q29617409 | ||
| Hepatitis B virus infection--natural history and clinical consequences | Q29617961 | ||
| Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
| Evolving epidemiology of hepatitis C virus | Q29619973 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| The global burden of hepatitis C | Q29620138 | ||
| Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis | Q30251862 | ||
| A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt | Q30403548 | ||
| Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. | Q30984322 | ||
| Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years | Q33575285 | ||
| Hepatitis B infection: pathogenesis and management | Q33870241 | ||
| The natural history of hepatitis C virus infection: host, viral, and environmental factors | Q33974693 | ||
| Epidemiology of hepatitis C virus (HCV) infection | Q33995067 | ||
| Global challenges in liver disease | Q33999114 | ||
| Chronic hepatitis B. | Q34002160 | ||
| Hepatitis B virus infection. | Q34002744 | ||
| The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. | Q34004939 | ||
| Viral hepatitis in HIV infection | Q34086980 | ||
| Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures | Q34302587 | ||
| Epidemiology of hepatitis B infection in the Western Pacific and South East Asia | Q34441984 | ||
| The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa | Q34442061 | ||
| Hepatitis B virus infection: epidemiology and vaccination | Q34534731 | ||
| Hepatitis C: an epidemiological review | Q34551348 | ||
| HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies | Q34561257 | ||
| Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment | Q34575206 | ||
| Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa | Q34683612 | ||
| Global control of hepatitis B virus infection. | Q34749752 | ||
| Occult hepatitis B. | Q34768651 | ||
| Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users | Q34779935 | ||
| Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV. | Q35010687 | ||
| Epidemiology of hepatitis C virus infection in Australia | Q35071449 | ||
| Comorbidity-related treatment outcomes among HIV-infected adults in the Bronx, NY. | Q35078719 | ||
| Coinfection with HIV-1 and HCV--a one-two punch | Q35137038 | ||
| Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment | Q35151034 | ||
| Management of chronic hepatitis C. | Q35522138 | ||
| Hepatitis C and renal disease: an update | Q35547800 | ||
| Recommendations for identification and public health management of persons with chronic hepatitis B virus infection | Q37462589 | ||
| Hepatitis B and human immunodeficiency virus coinfection | Q37462593 | ||
| Multicountry burden of chronic hepatitis C viral infection among those aware of their diagnosis: a patient survey | Q37500066 | ||
| Viral hepatitis and HIV co-infection | Q37626908 | ||
| HIV/hepatitis B virus co-infection: current challenges and new strategies | Q37630062 | ||
| Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs). | Q37630805 | ||
| Hepatitis C and diabetes: one treatment for two diseases? | Q37664068 | ||
| Epidemiology of hepatitis B and C viruses: a global overview | Q37685594 | ||
| An overview about hepatitis C: a devastating virus | Q37719516 | ||
| Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies | Q37819088 | ||
| Natural history of chronic hepatitis B REVEALed | Q37842664 | ||
| Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat? | Q37958234 | ||
| Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer | Q37978202 | ||
| Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity | Q37978441 | ||
| Chronic hepatitis B infection. | Q38006145 | ||
| The burden of liver disease in human immunodeficiency virus-infected patients | Q38023749 | ||
| Management and treatment of chronic hepatitis C in HIV patients | Q38023753 | ||
| Challenges for HCV vaccine development in HIV-HCV coinfection | Q38036684 | ||
| Hepatitis C virus vaccines--progress and perspectives | Q38090215 | ||
| Epidemiology and natural history of HCV infection. | Q38118578 | ||
| Update on HIV/HCV coinfection. | Q38119893 | ||
| Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes | Q39147501 | ||
| Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. | Q39313231 | ||
| Severity and correlates of liver disease in hepatitis C virus-infected injection drug users | Q39600856 | ||
| Hepatitis C and progression of HIV disease | Q39607141 | ||
| Correlates of hepatitis C virus infections among injection drug users. | Q40453200 | ||
| The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes | Q41572327 | ||
| Hepatitis C: the clinical spectrum of disease | Q41598735 | ||
| Hepatitis C virus infection and the rising incidence of hepatocellular carcinoma | Q42335491 | ||
| JGH Foundation emerging leadership lecture. Significance of hepatitis B virus genotypes and mutations in the development of hepatocellular carcinoma in Asia | Q42481590 | ||
| Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution. | Q42836169 | ||
| Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). | Q42979089 | ||
| The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. | Q42987939 | ||
| Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic | Q42988800 | ||
| New insights into hepatitis B and C virus co-infection | Q42989312 | ||
| Unscrambling hepatitis C virus-host interactions | Q42994469 | ||
| Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group | Q43036483 | ||
| Hepatitis C virus infection and coinfection with human immunodeficiency virus: challenges and advancements in management | Q43038823 | ||
| "Anti-HBc alone" in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients | Q43070377 | ||
| Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death | Q43180169 | ||
| Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients. | Q43269082 | ||
| Efficacy of interferon (conventional, pegylated) and lamivudine for treatment of chronic hepatitis B: a systematic review | Q43299772 | ||
| Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection | Q43648279 | ||
| Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy | Q43693273 | ||
| Chronic hepatitis B infection: a global disease requiring global strategies | Q43847084 | ||
| Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study | Q43874625 | ||
| A tale of two viruses: hepatitis C in the age of HAART. | Q44275568 | ||
| Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects | Q44536687 | ||
| The hepatitis B. | Q44692517 | ||
| HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). | Q44933768 | ||
| The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. | Q44979610 | ||
| Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival | Q45334756 | ||
| The global health burden of hepatitis C virus infection | Q45365903 | ||
| Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey | Q45368706 | ||
| Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database | Q45401707 | ||
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study | Q45413375 | ||
| Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy | Q45424761 | ||
| Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy | Q45729963 | ||
| Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations | Q45788736 | ||
| Hepatitis C prevalence among HIV-positive MSM in San Francisco: 2004 and 2008. | Q46099850 | ||
| Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs | Q46162379 | ||
| Vaccination of children against hepatitis B in Mayotte, French Comoros Island | Q46328147 | ||
| The coming wave of HCV-related liver disease: dilemmas and challenges | Q46868566 | ||
| The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. | Q50177933 | ||
| Institute of Medicine recommendations for the prevention and control of hepatitis B and C. | Q51781125 | ||
| A mathematical model to estimate global hepatitis B disease burden and vaccination impact. | Q51961246 | ||
| Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. | Q53316441 | ||
| High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. | Q53394007 | ||
| Hepatitis B Virus Infection | Q54152887 | ||
| Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B | Q57205318 | ||
| Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B | Q58376631 | ||
| Hepatitis C and HIV-1 coinfection | Q35595027 | ||
| Global burden of disease (GBD) for hepatitis C. | Q35610002 | ||
| Viral hepatitis B. | Q35617319 | ||
| Viral hepatitis C. | Q35617324 | ||
| Epidemiology of hepatitis B in Europe and worldwide | Q35621655 | ||
| HIV-HBV coinfection--a global challenge | Q35678473 | ||
| HIV/hepatitis C coinfection natural history and disease progression | Q35801431 | ||
| New treatments for chronic hepatitis C. | Q35833006 | ||
| Hepatitis B: Epidemiology and prevention in developing countries. | Q35875838 | ||
| Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study. | Q35956072 | ||
| Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients | Q36139522 | ||
| Hepatitis C virus infection: the new global epidemic | Q36140671 | ||
| Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection | Q36208036 | ||
| Epidemiology and natural history of hepatitis B. | Q36231799 | ||
| Challenges and successes in developing new therapies for hepatitis C. | Q36233823 | ||
| Epidemiology of viral hepatitis and HIV co-infection | Q36341016 | ||
| Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies | Q36346436 | ||
| Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention | Q36388315 | ||
| New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods | Q36466447 | ||
| Hepatocellular carcinoma and hepatitis B virus | Q36467980 | ||
| Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection | Q36496627 | ||
| Seroprevalence and Risk Factors for Hepatitis C Virus Infection among General Population in Central Region of Yemen | Q36505749 | ||
| Treating chronic hepatitis B: today and tomorrow | Q36638614 | ||
| Hepatitis C virus: virology and life cycle | Q36756358 | ||
| Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel | Q36821911 | ||
| Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. | Q36821936 | ||
| Clinical implications of HIV and hepatitis B co-infection in Asia and Africa | Q36830375 | ||
| Future prospectives for the management of chronic hepatitis B. | Q36841719 | ||
| The epidemiology of hepatitis C infection in the United States | Q36892181 | ||
| Increase in hepatitis C virus incidence in HIV-1-infected patients followed up since primary infection | Q36928649 | ||
| Viral hepatitis and HIV coinfection | Q37043908 | ||
| The challenge of hepatitis C in the HIV-infected person | Q37054403 | ||
| Epidemiology and surveillance of hepatocellular carcinoma | Q37105532 | ||
| P433 | issue | 7 | |
| P921 | main subject | citation analysis | Q206276 |
| chronic hepatitis B | Q55779876 | ||
| chronic hepatitis | Q62019625 | ||
| P304 | page(s) | 545-559 | |
| P577 | publication date | 2016-03-30 | |
| P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
| P1476 | title | Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature | |
| P478 | volume | 23 |
| Q42318295 | Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation |
| Q59360448 | An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTEN |
| Q59349991 | Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trial |
| Q38904188 | Congenital and perinatally-acquired infections in resource-constrained settings |
| Q33557877 | Diagnosis of viral hepatitis |
| Q44464330 | Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses. |
| Q38955633 | Endemic prevalence of hepatitis B and C in Mongolia: A nationwide survey amongst Mongolian adults |
| Q36241034 | Hepatitis B virus strains from Rwandan blood donors are genetically similar and form one clade within subgenotype A1. |
| Q58704386 | Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients |
| Q91892126 | Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts |
| Q90656523 | Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis |
| Q28076883 | Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline |
| Q47548262 | Stage of disease in hepatitis B virus infection in Zambian adults is associated with large cell change but not well defined using classic biomarkers |
| Q40660180 | The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts |
| Q45325257 | The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4 |
| Q38385525 | Viral-Associated GN: Hepatitis B and Other Viral Infections |
Search more.